MenuМеню
  • Home
  • About Us
  • Medicines
  • Partnering
  • Professionals
  • Responsibility
  • News & Media
  • Careers
  • Investors
  • English
  • Bulgarian

News and Media

  • Financial News
  • News
  • Opinion Pieces
  • Press Releases
  • July 14, 2023

    Women in business are the bearer of wisdom and balance

    For 22 years at Tchaikapharma I have learned a lot – the key to success is to climb all the “steps” consistently – says Mgr. Pharm. Silvia Patrikova, member of the Board of Directors of Tchaikapharma   Ms. Patrikova, how would you introduce yourself in three sentences?   I graduated in Pharmacy at MU-Sofia and […]

  • July 3, 2023

    Tchaikapharma supports the global initiative “Stand up to Cancer”

    “Tchaikapharma is the first Bulgarian organization to support the Stand Up To Cancer initiative. What was your motivation and why now?   SU2C is massively supported by the entertainment industry and leading global media with a very critical and self-critical view on the funding and implementation of scientific programs and research. With one important exception […]

  • May 15, 2023

    Tchaikapharma was a gold partner in the second scientific conference “Fundamentals of cardiovascular pharmacopoeia – combination therapy”

    The second scientific conference “Fundamentals of Cardiovascular Pharmacotherapy – Combination Therapy” was held in Sofia between May 12-14, 2023 on the initiative of the Academy-Cardiology Foundation, Logartis Foundation and Arbilis Ltd, in collaboration with the Bulgarian Society of Pharmacy and the National Association of General Practitioners in Bulgaria. As a leading manufacturer of combination products […]

  • January 10, 2023

    Biser Georgiev: Supply disruptions and rising raw material prices could hamper antibiotic production

    “We have assured quantities of medicines manufactured at Tchaikapharma High Quality Medicines. Based on current consumption, we maintain a minimum of a 4-month supply. If there is increased demand, we are ready to respond.”

  • December 6, 2022

    At the end of a successful 2022. Tchaikapharma receives MA for a unique anti-gout drug

    Tchaikapharma’s latest medicinal product to receive marketing authorisation from the Bulgarian Drug Agency is Clopasa (colchicine) 0.5 mg tablets – the first gout treatment in the company’s broad portfolio.   Clopasa belongs to the group of medicines with antipathic action. It is used for the treatment of acute attacks of gout, in the condition of […]

  1. Previous
  2. 1
  3. 2
  4. 3
  5. 4
  6. 5
  7. 6
  8. 7
  9. ...
  10. 36
  11. Next
Copyright © 2010-2025 Tchaikapharma Inc.
  • Contact Us